By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astex Therapeutics 

436 Cambridge Science Park
Milton Road
Cambridge    CB4 0QA  United Kingdom
Phone: 44-0-1223-226200 Fax: 44-0-1223-226201



Company News
PharmaVentures Ltd Engaged by Astex Therapeutics to Assist in the Divestment of US Facility 9/9/2011 12:06:36 PM
SuperGen, Inc. (SUPG) Completes Acquisition of Astex Therapeutics 7/20/2011 10:47:32 AM
SuperGen, Inc. (SUPG) Stockholders Approve Stock Issuance In Connection with the Proposed Acquisition of Astex Therapeutics 6/17/2011 8:43:31 AM
Astex Therapeutics Achieves Milestones in GlaxoSmithKline (GSK) Collaboration 5/3/2011 9:42:19 AM
Astex Therapeutics Announces Commencement of Phase I Study for AZD5363 in Anti-Cancer Collaboration with AstraZeneca PLC (AZN) 4/12/2011 10:33:16 AM
SuperGen, Inc. (SUPG) and Astex Therapeutics Enter Definitive Merger Agreement, Creating a Financially Strong, International Oncology Company Astex Pharmaceuticals, Inc. 4/7/2011 12:35:56 AM
Astex Therapeutics Receives Milestone from Wellcome Trust for Pioneering HCV Research 2/1/2011 9:27:42 AM
Astex Therapeutics Announces Milestone in Oncology Collaboration 1/11/2011 10:25:50 AM
Astex Therapeutics to Present at Biotech Showcase 2011 1/5/2011 10:39:52 AM
Astex Therapeutics and the NCIC Clinical Trials Group Announce Start of Phase II Clinical Study of AT9283 in Multiple Myeloma 11/4/2010 6:29:29 AM